{
    "code": "02020670",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020670",
    "time": "2016-11-18 19:53:49",
    "許可證字號": "衛署藥輸字第020670號",
    "註銷狀態": "已註銷",
    "註銷日期": "86\/10\/27",
    "註銷理由": "移轉（申請商）",
    "有效日期": "88\/11\/09",
    "發證日期": "83\/11\/09",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202067001",
    "中文品名": "醯酸康杜若新鈉注射用",
    "英文品名": "SODIUM CHONDROITIN SULFATE FOR INJECTION",
    "適應症": "急慢性腎炎？腎性浮腫。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        "CHONDROITINSULFATESODIUM(EQTOSODIUMCHONDROITINSULFATE)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1412901100  嘉成藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260282000  SEIKAGAKU CORPORATION",
        "製造廠廠址": "7-3-1 KURIHAMA,YOKOSUKA-SHI,KANAGAWA PREFECTURE 239 JAPAN.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406000310",
            "成分名稱": "CHONDROITIN SULFATE SODIUM (EQ TO SODIUM CHONDROITIN SULFATE )",
            "含量描述": "2.5-2.9",
            "含量": "",
            "單位": "%"
        }
    ]
}